Drug Trial Radar · NCT02114528
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3
Actual
Start
Oct 2014
Primary completion
Nov 2015
Study completion Nov 2015
Sponsor
- Lead sponsor
- Ottawa Heart Institute Research CorporationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 15, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether catheter based ablation is better than conventional anti-arrhythmic drug (AAD) therapy for reducing recurrent shocks in patients with an implantable cardioverter defibrillator (ICD). The second purpose of the study is to determine the safety of catheter-based ablation and the effect on quality of life of patients. The study hypothesis is that catheter ablation is superior to AAD therapy in preventing recurrent ventricular arrhythmia in such subjects. This is a pilot trial which will provide data regarding recruitment potential and the feasibility of conducting a larger trial.
Conditions
- Ventricular Tachycardia
- Ventricular Arrhythmia
Interventions
Antiarrhythmic Drug TherapyDrug
Either one or more of the following antiarrhythmic drugs: sotalol, mexiletine, procainamide, or amiodarone.
Catheter ablationProcedure
Ventricular tachycardia catheter ablation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Appropriate ICD therapyTime frame: After 30 day treatment period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.